Downscheduling welcomed

time for change clock
Downscheduling of migraine treatments begins on 1 Feb The Pharmacy Guild of Australia welcomed the confirmed decision to down-schedule the migraine treatments sumatriptan and zolmitriptan to S3, or pharmacist-only, medicines. In a decision released on 7 May, the Therapeutic Goods Administration (TGA) scheduling committee decided Sumatriptan would be in Schedule 3 "when in divided oral

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Allergic rhinitis: more than a sniffle & a sneeze
Next The week in review